Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Characterization of interleukin-17-producing regulatory T cells in inflamed intestinal mucosa from patients with inflammatory bowel diseases.

Gastroenterology - 1 Mar 2011

Hovhannisyan Zaruhi, Treatman Jacquelyn, Littman Dan R, Mayer Lloyd

Abstract excerpt

BACKGROUND & AIMS: Interleukin (IL)-17-producing CD4(+) helper T cells (Th17) mediate mucosal immunity and are involved in the pathogenesis of inflammatory bowel disease (IBD). They are believed to arise from the same precursor population as regulatory T (Treg) cells, but little is known about how these T-cell subsets interact under chronic inflammatory conditions. We studied Th17 and Treg cells isolated from...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Colitis, Ulcerative
Share to Immunity, Mucosal

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Interleukin-17

Share to New York City

Share to Receptors, Antigen, T-Cell, alpha-beta

Share to T-Lymphocytes, Regulatory

Share to Th17 Cells

Share to Transforming Growth Factor beta1

Source

Open in PubMed Open full text

Identifiers

PMID: 21147109
DOI: 10.1053/j.gastro.2010.12.002
PMCID: PMC3049831

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Characterization of interleukin-17-producing regulatory T cells in inflamed intestinal mucosa from patients with inflammatory bowel diseases.PMID 21147109Read ↗

The role of IL-17-producing Foxp3+ CD4+ T cells in inflammatory bowel disease and colon cancer.Semantic proximity Read ↗

Th17 Cells as Potential Probiotic Therapeutic Targets in Inflammatory Bowel Diseases.Semantic proximity Read ↗

The Th17 Cell Population and the Immune Homeostasis of the Gastrointestinal TractSemantic proximity Read ↗

New Insights on CD8+ T Cells in Inflammatory Bowel Disease and Therapeutic Approaches.Semantic proximity Read ↗

Differential mucosal expression of Th17-related genes between the inflamed colon and ileum of patients with inflammatory bowel diseaseSemantic proximity Read ↗

Th17 plasticity and its changes associated with inflammatory bowel disease.Semantic proximity Read ↗

Regulatory T-cells: diverse phenotypes integral to immune homeostasis and suppression.Semantic proximity Read ↗

Crohn's disease: Th1, Th17 or both? The change of a paradigm: new immunological and genetic insights implicate Th17 cells in the pathogenesis of Crohn's disease.Semantic proximity Read ↗

Intestinal Regulatory T Cells as Specialized Tissue-Restricted Immune Cells in Intestinal Immune Homeostasis and Disease.Semantic proximity Read ↗

Intestinal neuroendocrine cells and goblet cells are mediators of IL-17A-amplified epithelial IL-17C production in human inflammatory bowel disease.Semantic proximity Read ↗

Increased CD4+CD45RA-FoxP3low cells alter the balance between Treg and Th17 cells in colitis mice.Semantic proximity Read ↗

Effector and suppressor T cells in celiac diseaseSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.